Literature DB >> 7032921

CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.

H T Mouridsen, T Palshof, E Engelsman, R Sylvester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7032921

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Changes in the hormone receptors of human breast carcinoma xenografts in nude mice by treatment with cytotoxic agents.

Authors:  J Koh; E Shiina; Y Hosoda; M Hashimoto; O Yamamoto; S Sakai; T Kubota; K Enomoto; O Abe
Journal:  Jpn J Surg       Date:  1990-01

2.  Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.

Authors:  H T Mouridsen; E Boesen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

3.  Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: preliminary report of a randomized study.

Authors:  C G Kardinal; M C Perry; V Weinberg; W Wood; S Ginsberg; R N Raju
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.